M. Samarkos

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

L. Pagano, M. Navrátil, M. Hoenigl, 2022, Frontiers in Oncology.

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

L. Pagano, F. Passamonti, F. Farina, 2022, Blood.

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

L. Pagano, Gina Varricchio, F. Farina, 2023, eClinicalMedicine.

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

A. Barać, Gina Varricchio, G. Nadali, 2024, EClinicalMedicine.